Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.50
-0.26 (-4.51%)
At close: May 14, 2026, 4:00 PM EDT
5.51
+0.01 (0.18%)
After-hours: May 14, 2026, 6:35 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $431.87 million as of May 14, 2026. Its market cap has increased by 231.85% in one year.
Market Cap
431.87M
Enterprise Value
246.19M
1-Year Change
231.85%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $431.87M, an increase of 59.15%. That is a compound annual growth rate of 20.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 446.51M | 3.20% |
| Dec 31, 2025 | 432.69M | 98.58% |
| Dec 31, 2024 | 217.89M | -69.68% |
| Dec 29, 2023 | 718.56M | 164.80% |
| Nov 3, 2023 | 271.36M | - |
View and export this data all the way back to 2023. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 455.11M |
| Prelude Therapeutics | 449.58M |
| Lyell Immunopharma | 443.78M |
| PureTech Health | 442.35M |
| Century Therapeutics | 429.24M |
| ADC Therapeutics | 427.36M |
| Autolus Therapeutics | 423.17M |
| Verastem | 413.88M |